{"context":{"query":">>uniprot>>reactome","source_dataset":"uniprot","target_dataset":"reactome"},"stats":{"queried":1,"total":71,"mapped":1},"pagination":{"has_next":false},"schema":"id|name|tax_id|is_disease_pathway","mappings":[{"input":"P01116","source":"P01116|GTPase KRas","targets":["R-HSA-6802946|Signaling by moderate kinase activity BRAF mutants|9606|true","R-HSA-6802955|Paradoxical activation of RAF signaling by kinase inactive BRAF|9606|true","R-HSA-8951936|RUNX3 regulates p14-ARF|9606|false","R-HSA-9648002|RAS processing|9606|false","R-HSA-9649948|Signaling downstream of RAS mutants|9606|true","R-HSA-9674555|Signaling by CSF3 (G-CSF)|9606|false","R-HSA-9680350|Signaling by CSF1 (M-CSF) in myeloid cells|9606|false","R-HSA-9753510|Signaling by RAS GAP mutants|9606|true","R-HSA-9753512|Signaling by RAS GTPase mutants|9606|true","R-HSA-112412|SOS-mediated signalling|9606|false","R-HSA-1169092|Activation of RAS in B cells|9606|false","R-HSA-1236382|Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants|9606|true","R-HSA-1250196|SHC1 events in ERBB2 signaling|9606|false","R-HSA-1250347|SHC1 events in ERBB4 signaling|9606|false","R-HSA-1433557|Signaling by SCF-KIT|9606|false","R-HSA-167044|Signalling to RAS|9606|false","R-HSA-171007|p38MAPK events|9606|false","R-HSA-179812|GRB2 events in EGFR signaling|9606|false","R-HSA-180336|SHC1 events in EGFR signaling|9606|false","R-HSA-186763|Downstream signal transduction|9606|false","R-HSA-1963640|GRB2 events in ERBB2 signaling|9606|false","R-HSA-210993|Tie2 Signaling|9606|false","R-HSA-2179392|EGFR Transactivation by Gastrin|9606|false","R-HSA-2424491|DAP12 signaling|9606|false","R-HSA-2428933|SHC-related events triggered by IGF1R|9606|false","R-HSA-2871796|FCERI mediated MAPK activation|9606|false","R-HSA-375165|NCAM signaling for neurite out-growth|9606|false","R-HSA-4086398|Ca2+ pathway|9606|false","R-HSA-442982|Ras activation upon Ca2+ influx through NMDA receptor|9606|false","R-HSA-5218921|VEGFR2 mediated cell proliferation|9606|false","R-HSA-5621575|CD209 (DC-SIGN) signaling|9606|false","R-HSA-5637810|Constitutive Signaling by EGFRvIII|9606|true","R-HSA-5654688|SHC-mediated cascade:FGFR1|9606|false","R-HSA-5654693|FRS-mediated FGFR1 signaling|9606|false","R-HSA-5654699|SHC-mediated cascade:FGFR2|9606|false","R-HSA-5654700|FRS-mediated FGFR2 signaling|9606|false","R-HSA-5654704|SHC-mediated cascade:FGFR3|9606|false","R-HSA-5654706|FRS-mediated FGFR3 signaling|9606|false","R-HSA-5654712|FRS-mediated FGFR4 signaling|9606|false","R-HSA-5654719|SHC-mediated cascade:FGFR4|9606|false","R-HSA-5655253|Signaling by FGFR2 in disease|9606|true","R-HSA-5655291|Signaling by FGFR4 in disease|9606|true","R-HSA-5655302|Signaling by FGFR1 in disease|9606|true","R-HSA-5655332|Signaling by FGFR3 in disease|9606|true","R-HSA-5658442|Regulation of RAS by GAPs|9606|false","R-HSA-5673000|RAF activation|9606|false","R-HSA-5673001|RAF/MAP kinase cascade|9606|false","R-HSA-5674135|MAP2K and MAPK activation|9606|false","R-HSA-5675221|Negative regulation of MAPK pathway|9606|false","R-HSA-6802948|Signaling by high-kinase activity BRAF mutants|9606|true","R-HSA-6802952|Signaling by BRAF and RAF1 fusions|9606|true","R-HSA-6802953|RAS signaling downstream of NF1 loss-of-function variants|9606|true","R-HSA-74751|Insulin receptor signalling cascade|9606|false","R-HSA-8849471|PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases|9606|false","R-HSA-8851805|MET activates RAS signaling|9606|false","R-HSA-9026519|Activated NTRK2 signals through RAS|9606|false","R-HSA-9027284|Erythropoietin activates RAS|9606|false","R-HSA-9028731|Activated NTRK2 signals through FRS2 and FRS3|9606|false","R-HSA-9034864|Activated NTRK3 signals through RAS|9606|false","R-HSA-9607240|FLT3 Signaling|9606|false","R-HSA-9634285|Constitutive Signaling by Overexpressed ERBB2|9606|true","R-HSA-9634635|Estrogen-stimulated signaling through PRKCZ|9606|false","R-HSA-9656223|Signaling by RAF1 mutants|9606|true","R-HSA-9664565|Signaling by ERBB2 KD Mutants|9606|true","R-HSA-9665348|Signaling by ERBB2 ECD mutants|9606|true","R-HSA-9665686|Signaling by ERBB2 TMD/JMD mutants|9606|true","R-HSA-9670439|Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants|9606|true","R-HSA-9673767|Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants|9606|true","R-HSA-9673770|Signaling by PDGFRA extracellular domain mutants|9606|true","R-HSA-9703465|Signaling by FLT3 fusion proteins|9606|true","R-HSA-9703648|Signaling by FLT3 ITD and TKD mutants|9606|true"]}]}